Natural Killer Cell-Enriched Donor Lymphocyte Infusions from A 3-6/6 HLA Matched Family Member following Nonmyeloablative Allogeneic Stem Cell Transplantation
Open Access
- 25 February 2010
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 16 (8) , 1107-1114
- https://doi.org/10.1016/j.bbmt.2010.02.018
Abstract
No abstract availableKeywords
Funding Information
- Leukemia Lymphoma Society Clinical Scholar Award (D.A.R.), National Marrow Donor Program (D.A.N.), Adler Foundation (D.A.R. and D.M.)
This publication has 36 references indexed in Scilit:
- Loss of Mismatched HLA in Leukemia after Stem-Cell TransplantationNew England Journal of Medicine, 2009
- NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responsesBlood, 2009
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificityBlood, 2009
- Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemiaBlood, 2009
- Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantationBritish Journal of Haematology, 2008
- Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin LymphomaTransplantation and Cellular Therapy, 2008
- Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3–6/6 HLA matched donorsBone Marrow Transplantation, 2008
- Human natural killer cellsBlood, 2008
- Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.Blood, 2007
- A Phase I Study ofIn vitroExpanded Natural Killer T Cells in Patients with Advanced and Recurrent Non–Small Cell Lung CancerClinical Cancer Research, 2006